Renal Cancer - Results from #2740

Safety and efficacy of CDX-014, an antibody-drug conjugate directed against T cell immunoglobulin mucin-1 in advanced renal cell carcinoma. June 2, 2020

Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma. June 2, 2020

Sunitinib Versus Sorafenib as Initial Targeted Therapy for mCC-RCC With Favorable/Intermediate Risk: Multicenter Randomized Trial CROSS-J-RCC. June 1, 2020

Efficacy of Savolitinib vs Sunitinib in Patients With MET-Driven Papillary Renal Cell Carcinoma The SAVOIR Phase 3 Randomized Clinical Trial May 29, 2020

Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma. May 29, 2020

New Treatments in Renal Cancer: The AhR Ligands. May 29, 2020

Identification of low-dose multidrug combinations for sunitinib-naive and pre-treated renal cell carcinoma. May 28, 2020

Personalized neoantigen-based immunotherapy for advanced collecting duct carcinoma: case report. May 28, 2020

Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup. May 28, 2020

Partial vs. radical nephrectomy and the risk of all-cause mortality, cardiovascular, and nephrological outcomes. May 28, 2020

Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02). May 27, 2020

Bone metastasis is associated with poor prognosis in metastatic papillary renal cell carcinoma patients treated with first agent angiogenesis inhibitors. May 27, 2020

Molecular targeting of renal cell carcinoma by an oral combination. May 27, 2020

Long Non-Coding RNA TTN-AS1 Serves as a Competing Endogenous RNA of miR-195 to Facilitate Clear Cell Renal Cell Carcinoma Progression. May 27, 2020

The renal cell cancer database Sweden (RCCBaSe) - a new register-based resource for renal cell carcinoma research. May 26, 2020

Analyzing National Incidences and Predictors of Open Conversion During Minimally Invasive Partial Nephrectomy for cT1 Renal Masses. May 26, 2020

Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non-clear Cell Renal Cell Carcinoma Patients. May 26, 2020

Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. May 25, 2020

Advancing the Science and Management of Renal Cell Carcinoma: Bridging the Divide between Academic and Community Practices. May 25, 2020

Lymph node yield in pediatric, adolescent and young adult Renal Cell Carcinoma - How many are enough? May 22, 2020

Page 138 of 456